Literature DB >> 3710012

Acute reduction of arterial blood pressure reduces urinary albumin excretion in type 1 (insulin-dependent) diabetic patients with incipient nephropathy.

E Hommel, E Mathiesen, B Edsberg, M Bahnsen, H H Parving.   

Abstract

The effect of an acute reduction in arterial blood pressure upon kidney function was studied in 12 patients with Type 1 (insulin-dependent) diabetes and incipient nephropathy (persistent microalbuminuria). Renal function was assessed by measurement of the glomerular filtration rate (single bolus 51Cr-EDTA technique) and by the urinary albumin excretion rate (radioimmunoassay). The study was performed twice within 2 weeks, with the patients receiving a slow intravenous injection of either clonidine (225 micrograms) or saline (154 mmol/l) in random order. Clonidine reduced arterial blood pressure from 125/79 +/- 13/8 to 104/68 +/- 9/7 mmHg (p less than 0.01), urinary albumin excretion rate from 68 (31-369) to 46 (6-200) micrograms/min (median and range) (p less than 0.01), and fractional clearance of albumin in all patients (median 29%) (p less than 0.01). Glomerular filtration rate was 110 +/- 11 before and 106 +/- 13 ml/min/1.73 m2 after clonidine injection. The blood glucose concentration was 15 +/- 4 mmol/l before and 14 +/- 5 mmol/l after clonidine injection. In agreement with findings in animal studies, our results suggest that microalbuminuria is to a large extent pressure-dependent, probably because of glomerular hypertension, and that autoregulation of glomerular filtration rate is normal in most patients with incipient diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3710012     DOI: 10.1007/bf00454877

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  42 in total

1.  The effect of metabolic regulation on microvascular permeability to small and large molecules in short-term juvenile diabetics.

Authors:  H H Parving; I Noer; T Deckert; P E Evrin; S L Nielsen; J Lyngsoe; C E Mogensen; M Rorth; P A Svendsen; J Trap-Jensen; N A Lassen
Journal:  Diabetologia       Date:  1976-05       Impact factor: 10.122

2.  Abnormal albumin excretion after two provocative renal tests in diabetes: physical exercise and lysine injection.

Authors:  C E Mogensen; E Vittinghus; K Sølling
Journal:  Kidney Int       Date:  1979-09       Impact factor: 10.612

Review 3.  Magnitude of the renal failure problem in diabetic patients.

Authors:  H C Knowles
Journal:  Kidney Int Suppl       Date:  1974-10       Impact factor: 10.545

4.  Unilateral nodular diabetic glomerulosclerosis (Kimmelstiel-Wilson): report of a case.

Authors:  J Berkman; H Rifkin
Journal:  Metabolism       Date:  1973-05       Impact factor: 8.694

5.  Kidney function and glomerular permeability to macromolecules in juvenile diabetes with special reference to early changes.

Authors:  C E Mogensen
Journal:  Dan Med Bull       Date:  1972-09

6.  Incipient nephropathy in type 1 (insulin-dependent) diabetes.

Authors:  E R Mathiesen; B Oxenbøll; K Johansen; P A Svendsen; T Deckert
Journal:  Diabetologia       Date:  1984-06       Impact factor: 10.122

7.  Predicting diabetic nephropathy in insulin-dependent patients.

Authors:  C E Mogensen; C K Christensen
Journal:  N Engl J Med       Date:  1984-07-12       Impact factor: 91.245

8.  Renal function in streptozotocin-diabetic rats.

Authors:  P K Jensen; J S Christiansen; K Steven; H H Parving
Journal:  Diabetologia       Date:  1981-10       Impact factor: 10.122

9.  Effect of control of blood glucose on urinary excretion of albumin and beta2 microglobulin in insulin-dependent diabetes.

Authors:  G C Viberti; J C Pickup; R J Jarrett; H Keen
Journal:  N Engl J Med       Date:  1979-03-22       Impact factor: 91.245

10.  Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy.

Authors:  C E Mogensen
Journal:  Br Med J (Clin Res Ed)       Date:  1982-09-11
View more
  19 in total

1.  Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy.

Authors:  E Hommel; P Andersen; M A Gall; F Nielsen; B Jensen; P Rossing; J Dyerberg; H H Parving
Journal:  Diabetologia       Date:  1992-05       Impact factor: 10.122

Review 2.  ACE inhibitors in the prevention and therapy of diabetic nephropathy. What is their role?

Authors:  C C Kelleher
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

3.  A double-blind crossover study of oral xamoterol in postural hypotension due to diabetic autonomic neuropathy.

Authors:  P J Leslie; C Thompson; B F Clarke; D J Ewing
Journal:  Clin Auton Res       Date:  1991-06       Impact factor: 4.435

4.  Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria.

Authors:  M Marre; H Leblanc; L Suarez; T T Guyenne; J Ménard; P Passa
Journal:  Br Med J (Clin Res Ed)       Date:  1987-06-06

5.  Albuminuria in type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in Pima Indians.

Authors:  R G Nelson; C L Kunzelman; D J Pettitt; M F Saad; P H Bennett; W C Knowler
Journal:  Diabetologia       Date:  1989-12       Impact factor: 10.122

6.  Prevalence of microalbuminuria in children with type 1 (insulin-dependent) diabetes mellitus.

Authors:  E R Mathiesen; N Saurbrey; E Hommel; H H Parving
Journal:  Diabetologia       Date:  1986-09       Impact factor: 10.122

7.  Renal protective effect of enalapril in diabetic nephropathy.

Authors:  S Björck; H Mulec; S A Johnsen; G Nordén; M Aurell
Journal:  BMJ       Date:  1992-02-08

8.  Persistent microalbuminuria in adolescents with type I (insulin-dependent) diabetes mellitus is associated to early rather than late puberty. Results of a prospective longitudinal study.

Authors:  M Janner; S E Knill; P Diem; K A Zuppinger; P E Mullis
Journal:  Eur J Pediatr       Date:  1994-06       Impact factor: 3.183

9.  Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy.

Authors:  S Björck; H Mulec; S A Johnsen; G Nyberg; M Aurell
Journal:  BMJ       Date:  1990-04-07

Review 10.  Enalapril. A reappraisal of its pharmacology and therapeutic use in hypertension.

Authors:  P A Todd; K L Goa
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.